'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, ...

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In this article, we are going ...

For this article, we compiled a list of 7 stocks that were discussed by Jim Cramer during the recent episode of Mad Money on ...

CNBC’s Jim Cramer examined Wednesday’s market rally and stressed that it’s important to stay focused on corporate earnings ...

We recently published a list of Jim Cramer’s Latest Lightning Round: Top 10 Stocks. In this article, we are going to take a ...

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In this article, we are going ...

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

CNBC’s Jim Cramer on Friday told investors why he thinks it’s a good time to buy sports betting platform DraftKings, whose ...

The server maker, shares of which were the most volatile in the S&P 500 last year, has yet to make public its earnings for ...

We recently compiled a list of the Jim Cramer Talked About These 9 Nuclear Power and Quantum Computing Stocks. In this ...

CNBC's Jim Cramer examined Monday's market action, saying the tech-heavy Nasdaq failed to rally largely due to a unique one-two punch: The U.S. government and billionaire Meta CEO Mark Zuckerberg. The ...